论文部分内容阅读
目的探讨盐酸氨溴索联合博利康尼驱动雾化吸入治疗毛细支气管炎的治疗效果。方法72例毛细支气管炎患儿随机分为治疗组34例与对照组38例。治疗组:博利康尼雾化液2.5mg/次及盐酸氨溴索7.5mg/次;对照组:α-糜蛋白酶5mg/次。每组药物均加入生理盐水5ml稀释,以空气压缩泵雾化吸入,2次/d,每次5～10min,连用5～7d。观察各组咳嗽消失、呼吸困难消失、哮鸣音消失及平均治疗时间。结果咳嗽消失、呼吸困难消失、哮鸣音消失及平均治疗时间治疗组与观察组比较明显缩短,差异均有统计学意义(P<0.05)。结论盐酸氨溴索联合博利康尼驱动雾化吸入治疗毛细支气管炎能增强疗效,缓解症状,缩短病程,提高治愈率。
Objective To investigate the therapeutic effect of ambroxol hydrochloride combined with boliqiani inhalation on bronchiolitis. Methods 72 children with bronchiolitis were randomly divided into treatment group 34 cases and control group 38 cases. Treatment group: Bolicilli aerosol 2.5mg / ambroxol hydrochloride 7.5mg / time; control group: α-chymotrypsin 5mg / time. Each group of drugs were diluted 5ml normal saline, aerosol inhalation by air compression pump, 2 times / d, each 5 ~ 10min, once every 5 ~ 7d. Cough disappeared, dyspnea disappeared, wheeze disappeared and the average treatment time was observed in each group. Results cough disappeared, dyspnea disappeared, wheeze disappeared and the average treatment time was significantly shorter in the treatment group and the observation group, the difference was statistically significant (P <0.05). Conclusion Ambroxol hydrochloride combined with Boli Kang Ni inhalation inhalation treatment of bronchiolitis can enhance the efficacy, relieve symptoms, shorten the course of disease and improve the cure rate.